Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Pharmacology|September 1, 1993
Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteersG A Marbet, M Verstraete, J Kienast, et al.
Leukemia|August 1, 1994
Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)C Fonatsch, H Gudat, E Lengfelder, et al.
European Radiology|January 14, 2017
Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosisJ J Vehreschild, C P Heussel, A H Groll, et al.
Current Research in Translational Medicine|November 11, 2017
How to build an allogeneic hematopoietic cell transplant unit in 2016: Proposal for a practical frameworkM Crysandt, I Yakoub-Agha, P Reiß, et al.
The Journal of Hospital Infection|November 14, 2018
Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016S M Heimann, M J G T Vehreschild, O A Cornely, et al.
Infection|June 29, 2006
A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial IIX Schiel, H Link, G Maschmeyer, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 23, 2003
["Problem-based learning--inflammation and transplantation": an integrated, subject-centred course in the clinical section of the medical curriculum at the medical school of the University of Muenster]H Herbst, M Zühlsdorf, B Sinha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncologyW H Krüger, J Bohlius, O A Cornely, et al.
Bone Marrow Transplantation|February 5, 2013
CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCTF Rosenow, A Berkemeier, U Krug, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)M Schmidt-Hieber, G Silling, E Schalk, et al.
Pageof 3